prikaz prve stranice dokumenta Benign Fasciculation Syndrome and Migraine Aura without Headache: Possible Rare Side Effects of the BNT162b2 mRNA Vaccine? A Case Report and a Potential Hypothesis
  Download
PDF 503.79 KB
Scientific paper - Case study
Benign Fasciculation Syndrome and Migraine Aura without Headache: Possible Rare Side Effects of the BNT162b2 mRNA Vaccine? A Case Report and a Potential Hypothesis
Vaccines, 10 (2022), 1; 117. https://doi.org/10.3390/vaccines10010117
Salai, Grgur; Bilić, Ervina; Primorac, Dragan; Lakušić, Darija Mahovic; Bilić, Hrvoje; Lazibat, Ines; Grgurević, Lovorka

Linked objects
COVID-19 | Virtual collection

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Salai, G., Bilić, E., Primorac, D., Lakušić, D. M., Bilić, H., Lazibat, I. & Grgurević, L. (2022). Benign Fasciculation Syndrome and Migraine Aura without Headache: Possible Rare Side Effects of the BNT162b2 mRNA Vaccine? A Case Report and a Potential Hypothesis. Vaccines, 10. (1). doi: 10.3390/vaccines10010117

Salai, Grgur, et al. "Benign Fasciculation Syndrome and Migraine Aura without Headache: Possible Rare Side Effects of the BNT162b2 mRNA Vaccine? A Case Report and a Potential Hypothesis." Vaccines, vol. 10, no. 1, 2022. https://doi.org/10.3390/vaccines10010117

Salai, Grgur, Ervina Bilić, Dragan Primorac, Darija Mahovic Lakušić, Hrvoje Bilić, Ines Lazibat and Lovorka Grgurević. "Benign Fasciculation Syndrome and Migraine Aura without Headache: Possible Rare Side Effects of the BNT162b2 mRNA Vaccine? A Case Report and a Potential Hypothesis." Vaccines 10, no. 1 (2022). https://doi.org/10.3390/vaccines10010117

Salai, G., et al. (2022) 'Benign Fasciculation Syndrome and Migraine Aura without Headache: Possible Rare Side Effects of the BNT162b2 mRNA Vaccine? A Case Report and a Potential Hypothesis', Vaccines, 10(1). doi: 10.3390/vaccines10010117

Salai G, Bilić E, Primorac D, Lakušić DM, Bilić H, Lazibat I, and sur.. Benign Fasciculation Syndrome and Migraine Aura without Headache: Possible Rare Side Effects of the BNT162b2 mRNA Vaccine? A Case Report and a Potential Hypothesis. Vaccines [Internet]. 2022 January 13 [cited 2024 November 30];10(1). doi: 10.3390/vaccines10010117

G. Salai, et al., "Benign Fasciculation Syndrome and Migraine Aura without Headache: Possible Rare Side Effects of the BNT162b2 mRNA Vaccine? A Case Report and a Potential Hypothesis", Vaccines, vol. 10, no. 1, January 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:649470. [Accessed: 30 November 2024]

Metadata
Title (english)Benign Fasciculation Syndrome and Migraine Aura without Headache: Possible Rare Side Effects of the BNT162b2 mRNA Vaccine? A Case Report and a Potential Hypothesis
AuthorGrgur Salai
AuthorErvina Bilić
AuthorDragan Primorac
AuthorDarija Mahovic Lakušić
AuthorHrvoje Bilić
AuthorInes Lazibat
AuthorLovorka Grgurević
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Biology and Medical Genetics)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
The BNT162b2 (Pfizer BioNTech) mRNA vaccine is an effective vaccine against COVID-19 infection. Here, we report an adverse event following immunization (AEFI) in a 48-year-old female patient who presented with fasciculations, migraine auras without headaches and in an increased discomfort of previously present palpitations, as well as excitation and insomnia. Her fasciculations were intermittently present until the time this paper was written, starting from the 6th day post-vaccination; they changed localization and frequency, but most commonly they were generalized, affecting almost all muscle groups. The patient also suffered from two incidents of migraine auras with visual kaleidoscope-like phenomena without headaches a few months after the vaccination. These symptoms were considered to be AEFI and no causal relation with the vaccine could be proven.
Keywords (english)
Languageenglish
Publication typeScientific paper - Case study
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleVaccines
Numberingvol. 10, no. 1, 117
e-ISSN2076-393X
DOIhttps://doi.org/10.3390/vaccines10010117
URN:NBNurn:nbn:hr:184:649470
Publication2022-01-13
Document URLhttps://www.mdpi.com/2076-393X/10/1/117
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2022-03-16 22:40:17